Archive for the ‘research’ Category

‘Bad Batch’ Vaccine Study: Some Batches Drove 80X Adverse Reactions

https://drdrew.com/2026/new-vaccine-study-some-batches-drove-80x-bad-reactions-says-danish-md-rare-diseases-expert-ask-dr-drew/

‘Bad Batch’ Vaccine Study: Some Batches Drove 80x Adverse Reactions, Says Danish MD & Rare Diseases Expert – Ask Dr. Drew

  • June 25, 2026

with Dr. Vibeke Maniche, Michael Pack & Rand Courtney

A new peer-reviewed study of nationwide German data finds suspected adverse-event reports for COVID-19 vaccines were sharply elevated in the earliest weeks of rollout, then fell suddenly. The authors call it a possible batch-dependent safety signal. Danish physician Dr. Vibeke Manniche, the study’s lead author and the only Danish doctor to speak out publicly against lockdow’ns from the start, joins to break down the findings.

Published in the International Journal of Risk & Safety in Medicine, the analysis covers the first three and a half years of Germany’s vaccination campaign. For one product, early-rollout reporting rates were roughly 80 times higher than the rates seen just weeks later.

Dr. Manniche also makes the case for why the US could learn from Denmark’s childhood vaccine schedule. Filmmaker Michael Pack, president of Palladium Pictures, discusses their new WSJ Opinion documentary “The Lockdown Dissidents.” Director Rand Courtney speaks on “La Lucha: Getting Schooled in America,” which follows five teens through poverty, trauma, and a broken school system. Dr. Drew is featured in the film.


For more:

Category:

Activism, research, vaccines

There’s a New Type of Lyme Disease in NY. OY.

https://medicaldetective.substack.com/p/theres-a-new-type-of-lyme-disease-in-new-york-state-oy

There’s A New Type of Lyme disease in New York State. Oy.

Richard Horowitz

Jun 10, 2026

There are very few headlines that catch my eye. This one was surprising but not unexpected, since ticks are known to spread via travel on birds (and air travel has become more expensive these days, as I just found out after booking several flights). Here is the news release that made me pay more attention:

https://www.nbcnews.com/health/health-news/lyme-disease-rare-type-found-first-time-new-york-symptoms-severe-rcna348491

So what exactly is the ‘new type of Lyme disease (LD)’? It’s a strain of LD that is not normally found in NY State. Its Borrelia mayonii. The CDC just reported on it in their MMWR report. Here is a brief summary:

[From: Nafiz TN, Prusinski MA, Gubbala S, et al. Notes from the Field: Borrelia mayonii Lyme Disease — New York, 2025. MMWR Morb Mortal Wkly Rep 2026;75:271–272. DOI: http://dx.doi.org/10.15585/mmwr.mm7521a2]

This is an important case study, because B. mayonii clinically presents differently than an infection with Borrelia burgdorferi (Bb), so we need to understand how to properly diagnose and treat it if it is being found in new areas. (See link for article)

________________

**Comment**

Dr. Horowitz points out that the rash with B. mayonii is not the ‘classic’ rash seen with Bb, which isn’t so classic either, and highly variable – although it’s completely diagnostic, proving infection – no testing even required. If you have the rash, you are infected, period.

But there is concern for more severe systemic illness with B. mayonii due to a high level of spirochetes in the blood.

For more:

Category:

Lyme, research, Ticks, Transmission, Treatment

Engineered Alpha-Gal Ticks, GMO Mosquitoes, Flesh-Eating Screwworm, & 6G Control Grid Exposed

Engineered Alpha-Gal Ticks & Flesh-Eating Screwworm

Dr Kelly Victory & Nic Hulscher

6/10/26

Nicolas Hulscher is an epidemiologist and administrator at the McCullough Foundation. He earned a Master of Public Health degree with a specialization in epidemiology at Michigan School of Public Health. He has contributed to the publication of more than 25 scientific studies, advancing understanding of COVID-19 vaccine injuries, childhood vaccine injuries, cancer treatments, SARS-CoV-2, and H5N1 avian influenza. Follow at https://x.com/NicHulscher

Dr. Kelly Victory is Chief of Emergency & Disaster Medicine at The Wellness Company. A trauma and emergency specialist with over 30 years of experience, she served as Chief Medical Officer for Fortune 500 companies and is an alumna of Harvard’s National Preparedness Leadership Initiative. She is a contributing author of “Toxic Shot: Facing the Dangers of the COVID Vaccines.” Find more at https://x.com/DrKellyVictory

Scroll to about 22 minutes to hear about Alpha Gal.

Chapters

  • 0:00 – Dr. Kelly Victory LIVE on Ask Dr. Drew
  • 8:24 – Dr. Drew (From Europe!) On California’s Bizarre Primary Election
  • 10:34 – Producer Kaleb Nation: Wife’s Friend Cut Her Off Over Spencer Pratt Misinformation ‪@kalebnation‬
  • 24:28 – What Is Alpha-Gal Syndrome?
  • 32:55 – The Plum Island Lab & Lyme Disease Connection
  • 40:21 – Surprising Acupuncture Results Against Alpha-Gal
  • 47:32 – The New World Screwworm Outbreak
  • 48:38 – Ivermectin’s Effectiveness On Screwworm Parasites
  • 55:11 – The Nonstop Cycle Of Global Viral Scares
  • 1:01:17 – Big Pharma Flags Highly Popular Cancer Research Study

GMO Mosquitoes, Weaponized Ticks & Brain Chips: The 6G Control Grid Exposed w/ Nicolas Hulscher

Google just filed to release 64 million bacteria-infected mosquitoes across California and Florida, alpha-gal syndrome has surged 10,000% since 2013 making people violently allergic to red meat, and 6G, the network being quietly built right now, is designed to interface directly with brain chips inside the human body. In this episode, epidemiologist Nicolas Hulscher of the McCullough Foundation connects all of it: engineered insects, tick-borne bioterrorism, the Gates Foundation’s fingerprints across both, and the transhumanist control grid being assembled in plain sight.

For more:

More on Ivermectin:

Do not believe anything the FDA says!

Category:

Alpha Gal Meat Allergy, Parasites, research, Ticks, Treatment, Uncategorized

How They Rig Clinical Trials & The Price We All Pay For It

https://www.midwesterndoctor.com/p/how-they-rig-clinical-trials-leaving?

How They Rig Clinical Trials and The Price We All Pay For It

A practical guide to spotting doctored research and finding the therapies that actually help

A Midwestern Doctor

Jun 03, 2026

Story at a Glance:

  • Scientific research has provided immense benefit to society, but as its success earned it power, prestige and enormous financing, incentives shifted from advancing humanity to protecting the status quo and ensuring vast profits for the pharmaceutical industry.
  • We spend more and more on science each year, yet the problems we’ve tasked it with solving remain unsolved, even when solutions already exist. COVID-19 made this painfully clear: dozens of treatments existed for the disease, but rather than utilize them, the medical establishment treated the infection as “incurable” and used that framing to justify a series of counterproductive policies which devastated the economy and left us with a death toll well over a hundred times greater than the poorest nations that did nothing at all.
  • Central to maintaining this orthodoxy is the belief that large randomized controlled trials (RCTs) must serve as the primary arbiter of scientific truth while other viable and proven research approaches are discarded. While RCTs are sometimes immensely helpful, their data often has minimal clinical relevance to patients yet their dominance displaces all the scientific data which does.
  • Because large RCTs cost tens of millions of dollars, only a handful of parties can afford to conduct them, which means they are typically done to bring profitable products to market rather than to advance health. Worse, since so much money rides on each trial, perverse incentives always exist to doctor the results so a positive outcome is guaranteed.
  • Over the years, a robust system of ways to rig trials has emerged, with tactics that exaggerate or fabricate benefits while downplaying or erasing harms. Despite being well recognized, these tactics persist because the regulators and medical journals who depend on the status quo turn a blind eye.
  • This article provides a concise summary of how trials are routinely rigged, gives you the resources to spot this manipulation and protect yourself from it, and highlights the straightforward solutions that could bring science back to something that prioritizes advancing humanity.

How to Rig a Trial

Since the risks and benefits of a therapy are determined by it having a “statistically significant” improvement from the comparison group (e.g., those receiving placebo), trials are typically gamed by:

  • Making the placebo group do worse, so that by comparison to that artificial baseline, the treatment appears better than it is.
  • Finding ways to inflate the positive effects reported for the treatment and eliminate the negative ones.
  • Finding ways to cast the results obtained in a more positive light and creatively downplay the negative ones.
  • Sifting through the random statistical variation inherent in any large trial to identify the specific analytical permutations where a “benefit” spontaneously appears, then presenting those selected findings as the definitive result.
  • Ensuring that almost everyone only sees the curated presentation of the trial data which makes the drug look as good as possible.

(See link for article)

_________________

**Comment**

The author shows how they rig the trial design, manipulate data mid-stream, game the analysis, control what gets published, spin the presentation, and control the narrative.

Each and everyone of these tacts has been used in Lyme/MSIDS, climate, and vaccine research. It’s all gamed for a predetermined outcome which has been killing patients for decades.

For more:

Category:

Activism, research

Seroprevalence of Borrelia, Anaplasma, Bartonella, Toxoplasma, Mycoplasma, Yersinia, and Chlamydia in Human Population From Eastern Poland

https://www.mdpi.com/2076-0817/14/1/96

Seroprevalence of Borrelia, Anaplasma, Bartonella,  Toxoplasma, Mycoplasma, Yersinia, and Chlamydia in Human Population from Eastern Poland

by Angelina Wójcik-Fatla 1, Anna Sawczyn-Domańska 1,*, Anna Kloc 1,Joanna Krzowska-Firych 2 and Jacek Sroka 1,3

*Author to whom correspondence should be addressed.

Pathogens 2025, 14(1), 96; https://doi.org/10.3390/pathogens14010096

Submission received: 3 December 2024 / Revised: 15 January 2025 / Accepted: 16 January 2025 / Published: 18 January 2025

(This article belongs to the Special Issue Exploring the Biodiversity of Parasites in Humans, Wild and Domestic Animals)

Abstract

The epidemiological situation related to infectious diseases is influenced by many factors. To monitor actual trends in selected zoonoses, a total of 473 serum samples from farmers, forestry workers, and veterinarians were collected for serological examination. Anti-Borrelia burgdorferi sensu lato (s.l.) antibodies were tested with ELISA and Western blot (WB) tests; the detection of anti-Toxoplasma gondii antibodies was performed using an enzyme linked fluorescence assay (ELFA). Antibodies to bartonellosis, anaplasmosis, and chlamydiosis were determined by indirect immunofluorescent test (IFA), whereas antibodies to yersiniosis and mycoplasmosis were confirmed in the ELISA test.

Positive or borderline results of antibodies against B. burgdorferi s.l. in the ELISA test were detected in 33.8% of the study population. The borderline or positive ELISA test results for at least one antibody class were confirmed by WB in 58.7% of cases. The IgG antibodies against Anaplasma phagocytophilum, Toxoplasma gondii, and Mycoplasma pneumoniae were detected in 9.6%, 51.7%, and 63.6% of samples, respectively. Antibodies against Yersinia spp., Bartonella henselae, and Chlamydia pneumoniae were found to vary between 43 and 47%.

Category:

Anaplasmosis, Bartonella, Lyme, Mycoplasma, research, Testing, Toxoplasmosis